DongKook Pharmaceutical (Korea) Investor Sentiment

086450 Stock  KRW 16,640  40.00  0.24%   
About 62% of DongKook Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in DongKook Pharmaceutical Co suggests that many traders are alarmed regarding DongKook Pharmaceutical's prospects. The current market sentiment, together with DongKook Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use DongKook Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
  
over a month ago at news.google.com         
Undiscovered Gems And 2 Other Hidden Small Caps With Strong Potential - Simply Wall St
Google News at Macroaxis
over a month ago at news.google.com         
S.Biomedics Co., Ltd. announced that it expects to receive KRW 1 billion in funding - Marketscreener...
Google News at Macroaxis
over a month ago at news.google.com         
Benign Prostatic Hyperplasia Clinical Trials 2024 FDA Approvals, Medication, Therapies, Treatment Ma...
Google News at Macroaxis
over three months ago at news.google.com         
HUMAN TECHNOLOGY Co., Ltds stock price dropped 10 percent last week retail investors would not be ha...
Google News at Macroaxis
over six months ago at news.google.com         
S. Korean pharma giants drive surge in derma cosmetics sales -
Google News at Macroaxis
over six months ago at news.google.com         
Benign Prostatic Hyperplasia Pipeline Drugs Analysis Report, 2024 Updates FDA Approvals, Clinical Tr...
Google News at Macroaxis
over six months ago at news.google.com         
Dongkuk Pharmaceuticals herbal medicine gum drug Insadol will enter the European market in earnest ....
Google News at Macroaxis
over a year ago at news.google.com         
New drug mispackaging incident hits 2 pharma firms - KBR
Google News at Macroaxis
over a year ago at news.google.com         
Will Dongkook Pharm present new combo therapy for BPH - KBR
Google News at Macroaxis
over a year ago at news.google.com         
Dongkook Pharm launches insulin biosimilar Glarzia - KBR
Google News at Macroaxis
over a year ago at news.google.com         
Icures GMP violations continue to cause ripples in pharma industry - KBR
Google News at Macroaxis
over a year ago at news.google.com         
Government incentives remain insufficient to localize APIs, essential drugs - KBR
Google News at Macroaxis
over a year ago at news.google.com         
Which are newly named as innovative pharmaceutical company in 2023 - KBR
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about DongKook Pharmaceutical that are available to investors today. That information is available publicly through DongKook media outlets and privately through word of mouth or via DongKook internal channels. However, regardless of the origin, that massive amount of DongKook data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of DongKook Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of DongKook Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to DongKook Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive DongKook Pharmaceutical alpha.

DongKook Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for DongKook Stock analysis

When running DongKook Pharmaceutical's price analysis, check to measure DongKook Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DongKook Pharmaceutical is operating at the current time. Most of DongKook Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of DongKook Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DongKook Pharmaceutical's price. Additionally, you may evaluate how the addition of DongKook Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope